Phase 2 Neoantigen Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Solid TumorsAdvanced CancerRecurrent Cancer+2 more

Seqker Biosciences, Inc.10 enrolled2 locationsNCT07002203

Recruiting

Phase 2

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)

Sichuan University165 enrolled1 locationNCT06675201